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Abstract
Background:  Carotid angioplasty and stenting (CAS) is often considered as the preferred
treatment for severe carotid occlusive disease in patients labelled as "high risk", including those
aged 80 or more. We analyzed 30-day stroke risk and death rates after carotid endarterectomy
(CEA) for severe symptomatic or asymptomatic carotid disease in patients aged 80 or more, by
comparison with the outcome of CAS reported in the recently- published literature.
Methods: A retrospective review was conducted on a prospectively compiled computerized
database of all primary CEAs performed by a single surgeon at our institution from 1990 to 2003.
Descriptive demographic data, risk factors, surgical details, perioperative strokes and deaths, and
other complications were recorded.
Results: In all, 1260 CEAs were performed in 1099 patients; 1145 were performed in 987 patients
less than 80 years old, and 115 were performed in 112 patients aged 80 or more. There were 11
perioperative strokes in the 1145 procedures in the younger group, for a stroke rate of 0.8%, and
no strokes in the 115 procedures in the older group. The death rates were 0% for the
octogenarians and 0.3% for the younger group.
Conclusion: The conviction that older age means higher risk needs to be revised. Patients aged
80 or more can undergo CEA with no more perioperative risks than younger patients. Proponents
of CAS should bear this in mind before recommending CAS as the best therapeutic option for such
patients.
Background
Carotid endarterectomy (CEA) has been established as the
gold standard for the treatment of both symptomatic and
asymptomatic high-grade (≥ 70%) internal carotid artery
(ICA) disease, based on the results of several prospective,
randomized controlled trials [1-5]. However, though eld-
erly people are typically seen in everyday clinical practice,
an increasingly important group of patients, i.e. those
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aged ≥ 80 years, was rarely recruited [1,2] or excluded
from the major surgical trials [3,6]. Due to concern about
the excessive risk of complications deriving from concom-
itant disease or limited post-procedural life expectancy,
these patients were labelled as "high risk" and diverted to
medical treatment or a seemingly less invasive procedure,
such as carotid angioplasty and stenting (CAS). Wherever
it was evaluated, best medical care proved less effective
than CEA [1-3,7], however, and the results of CAS in eld-
erly patients were hardly encouraging [8-10]. In fact,
though many single-centers studies reported that CAS can
be performed with acceptable periprocedural complica-
tion rates [11], advanced age was considered a significant
predictor of periprocedural neurological events after
unprotected and protected CAS procedures in several
recently-published large single- and multicenter trials [8-
10]. This finding is odd, but the authors did not attempt
to explain why the outcome of CAS should be signifi-
cantly worse in older than in younger patients. Indeed, if
older age really does mean a higher risk, one would expect
the less invasive procedure to be better tolerated by elderly
patients and produce better results than CEA. Although
reanalyzing outcome in the multicenter surgical trials on
the basis of age revealed that patients aged ≥ 75 years ben-
efited more from CEA than younger patients [12] (proba-
bly because elderly patients have a greater risk of ischemic
stroke on medical treatment and a lower surgical risk),
from the trial data it is impossible to say whether this also
applies to over 80-year-olds.
The aim of this study was to analyze the perioperative (30-
day) stroke risk and death rates of CEA in patients aged ≥
80 years, as compared with the outcome after CAS
reported in the recently-published literature.
Methods
A retrospective review was conducted on a prospectively
compiled computerized database of all primary CEAs per-
formed by a single surgeon at our institution from 1990
to 2003 in symptomatic and asymptomatic patients with
high-grade ICA lesions according to the recommenda-
tions of the North American Symptomatic Carotid Endar-
terectomy Trial (NASCET) [1] and the Asymptomatic
Carotid Atherosclerosis Study (ACAS) [3]. Patients sched-
uled for CEA with concomitant coronary artery bypass
grafting, or with associated supra-aortic trunk lesions
requiring concurrent surgery and patients requiring
carotid surgery for recurrent disease were ruled out.
The patients' demographic data were collected, including
any history of diabetes mellitus, cigarette smoking, hyper-
tension and coronary artery disease (CAD), other clinical
variables, indications for surgery, details of the operation
and hospital stay.
The ICA lesion was diagnosed on preoperative traditional
digital subtraction angiography (DSA) during the earlier
part of this experience (with declining frequency over the
years), while duplex ultrasonography scan (DUS) was the
only preoperative ICA imaging study performed in most
patients from mid-1998 onwards, combined in selected
patients with either magnetic resonance (MR) angiogra-
phy, computed tomography (CT) angiography, or tradi-
tional arteriography. The radiologist's estimate of any
carotid bulb or ICA stenosis in the final DSA report was
recorded using the NASCET method [1]. If no DSA was
performed, stenosis was estimated from the findings at
preoperative DUS, performed in our vascular laboratory.
The velocity criteria used to classify the degree of stenosis
revealed a satisfactory correlation with the DSA findings
when the degree of stenosis was calculated as the percent-
age of diameter reduction in compliance with the NAS-
CET method [1]. These criteria have been published
elsewhere [13,14], and are validated yearly. Clinical pres-
entation was always classified by the consultant neurolo-
gist as transient ischemic attack (TIA; i.e., temporary
hemispheric symptoms lasting no more than 24 hours,
with complete recovery), amaurosis fugax (transient
monocular visual loss), or stroke (neurological deficit per-
sisting more than 24 hours, regardless of the mechanism
and related to either cerebral hemisphere). Patients who
had non-hemispheric symptoms, such as dizzy spells or
vertigo, were included in the asymptomatic group. Preop-
erative cerebral CT was performed in all symptomatic
patients. Preoperative cardiac work-up was tailored to
each patient, on the basis of history, electrocardiographic
(ECG) findings, and symptoms. Patients with evidence of
clinically important CAD underwent echocardiography or
dipyridamole-thallium stress tests followed by coronary
arteriography as indicated. Pre- and postoperative cranial
nerve assessment was done in all patients by a neurologist
and an otolaryngologist. Vocal cord movements were
assessed by direct fiberoptic laryngoscopy in patients pre-
senting symptoms and/or signs of vagus nerve injury [15].
Preoperative patient preparation was standardized. To
reduce the incidence of neck hematoma, antiplatelet ther-
apy (aspirin or dipyridamole, and ticlopidine or clopidog-
rel in the final period) was suspended at least 1 week
before the operation, and was not resumed until the
patient was discharged from the hospital.
All CEA procedures involved either traditional CEA with
patching (n = 302) or eversion CEA (n = 958). The techni-
cal details of both procedures have been described else-
where [16,17]. All CEAs were performed with patients
under deep general anaesthesia and cerebral protection
involving continuous perioperative electroencephalo-
graphic monitoring (EEG) for selective shunting. All peri-
operative EEGs were visually analyzed by a neurologist
with an extensive experience in the interpretation of stud-BMC Cardiovascular Disorders 2006, 6:12 http://www.biomedcentral.com/1471-2261/6/12
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ies during sleep, either natural or induced by hypnotic or
anaesthetic agents. Shunting criteria were based exclu-
sively on EEG changes consistent with cerebral ischemia.
Completion imaging studies were never performed.
Patients were usually monitored in the recovery room for
2 hours until their blood pressure and neurological status
were considered acceptable before being transferred to a
regular nursing unit specializing in vascular care and
monitored for the next 12 to 24 hours after surgery. All
patients with severe headache were observed for hyperper-
fusion syndrome, and hypertension was treated aggres-
sively. Most patients were discharged 48–72 hours after
CEA.
The endpoints of this study were perioperative stroke and
death, and cardiac complications, which were prospec-
tively recorded according to the guidelines of the Ad Hoc
Committee on Reporting Standards for Cerebrovascular
Disease, Society for Vascular Surgery/North American
Chapter of the International Society of Cardiovascular
Surgery [18]. Minor stroke was defined as a focal neurolog-
ical deficit of acute onset, lasting more than 24 hours and
not leading to disability. Major stroke was defined as a
focal neurological deficit leading to disability and perma-
nent handicap.
All patients were assessed postoperatively by a consultant
neurologist at the awakening from the anaesthesia and
before the discharge. After discharge, visiting nurses mon-
itored the patients' blood pressure and neurological sta-
tus. Clinical evaluation and DUS were performed
systematically by a consultant neurologist and two experi-
enced technologists in all surviving patients at 1, 6 and 12
months, and once every postoperative year thereafter,
assessing any residual ICA stenosis, angulation, recurrent
ICA disease, or occlusion with an Acuson Sequoia 512
ultrasound system (Mountain View, Calif). Cerebral CT or
MR scans were performed in all patients presenting a new
neurological deficit.
Cardiac complications included: 1) myocardial infarction
(MI), with a diagnosis made on the basis of creatine
kinase enzyme levels and ECG findings; 2) pulmonary
edema confirmed by the official reading of the chest radi-
ograph; 3) documented ventricular fibrillation or primary
cardiac arrest; and 4) new complete heart block requiring
a pacemaker. A postoperative ECG was routinely obtained
in all patients who had a history of CAD, CHF, or arrhyth-
mia (rhythm other than sinus). Cardiac isoenzymes were
obtained in all patients who had new findings on the
postoperative ECG.
Data analysis
All statistical analyses were performed with the SPSS 10.0
statistical software package (SPSS, Chicago, Ill). Univari-
ate analysis was performed on all clinical, morphological,
and procedural variables, with Student's t test (two-tailed)
for continuous variables, and chi-square analysis (two-
tailed) for categorical variables. Statistical significance was
inferred for p < .05. Since each perioperative outcome was
correlated with the surgical procedure, and since patients
who underwent bilateral CEAs were exposed to twice the
risk of stroke or death, several data items were analyzed
vis-a-vis surgical procedures rather than patients.
Table 1: Baseline characteristics, and anatomical/technical data
Patients ≥ 80 yrs (n = 112) Patients < 80 yrs (n = 987) p value
CEAs, n 115 1145
Mean age, yrs (range) 84.2 (80–93) 67.6(31–79)
Male, n(%) 69(61.6) 672(68.1) .17
Risk factors
Hypertension, n(%) 79 (70.5) 575 (58.2) .01
Current smoking or past history of smoking, n(%) 86 (76.8) 697 (70.6) .19
Diabetes mellitus, n(%) 22 (19.6) 331 (30.1) .002
CAD, n(%) 52 (46.4) 446(45.1) .84
Symptomatic carotid disease, n(%) 76(66.1) 763 (66.7) .92
Asymptomatic carotid disease, n(%) 39 (33.9) 382 (33.3) .92
Contralateral carotid occlusion, n(%) 59 (52.6) 94 (9.5) <.001
CEA with patching, n(%) 35 (30.5) 267 (23.3) .11
Eversion CEA, n(%) 80 (69.5) 878 (76.7) .11
Intraoperative EEG changes, n(%) 52 (45.2) 202 (17.6) <.001
Shunting, n(%) 41 (35.6) 132(11.5) <.001
CEA, carotid endarterectomy; TIA, transient ischemic attack; CAD, coronary artery disease; EEG, electroencephalographic.BMC Cardiovascular Disorders 2006, 6:12 http://www.biomedcentral.com/1471-2261/6/12
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Results
Overall, 1260 CEAs were performed in 1099 patients, 112
of them were aged ≥ 80 years (10.2%; 129 CEAs), while
the other 987 patients (89.8%; 1131 CEAs) were younger.
The preoperative demographic data for the two groups
considered are shown in Table 1. The mean age was 84.2
years (range, 80 to 93) in the older group and 67.6 years
(range, 31 to 79) in the younger group. The incidence of
arterial hypertension was statistically higher in the older
group (70.5% vs 58.2%, p = .002), while older patients
were significantly less likely to have diabetes mellitus
(19.6% vs 30.1%, p = .01). There was no statistically sig-
nificant difference between the two groups in current or
past history of smoking, CAD, and indications for surgery.
The older patients experienced a statistically higher rate of
perioperative EEG changes suggestive of cerebral ischemia
requiring shunting (45.2% vs 17.6%, p < .001), so they
needed shunting statistically more often the younger
group (35.6% vs 11.5%, P < .001) (Table 1). The type of
CEA procedure used (traditional with patching or ever-
sion) was much the same in the two groups, but eversion
CEA was performed more often than traditional CEA,
both in the series as a whole (76% vs 24%, P < .001) and
in each group (69.5% vs 30.5% in the older group, p = <.
001; and 76.7% vs 23.3% in the younger group, p < .001)
(Table 1).
Perioperative mortality and stroke rates
Overall, the perioperative mortality rate was 0.2% (3 of
1260), and the stroke rate was 0.9% (11 of 1260) with a
combined mortality and stroke rate of 1.1% (Table 2). No
significant differences emerged between the two groups in
terms of perioperative neurological events or death. Peri-
operative death and stroke occurred only in the younger
group. There were 3 perioperative deaths: 2 due to MI, and
1 to stroke. The only fatal perioperative stroke occurred in
a patient with symptomatic disease undergoing CEA with
patching to treat a severe ulcerated left ICA lesion. All
remaining strokes (6 CEA procedures with patching, 4
eversion CEAs) occurred in symptomatic patients, and all
but two were major in severity. In all cases stroke occurred
within the first 24 hours of surgery, while the patient was
in the recovery room: DUS immediately confirmed an ICA
occlusion in the patched patients, whereas it demon-
strated ICA patency in the everted patients. Among the
patched patients, 4 underwent re-operation consisting of
a thrombectomy and new patch-plasty: there was some
improvement in the neurological status of only one
patient and none in the others. The remaining two strokes
involved the hemisphere contralateral to the operated
side (one of these was ipsilateral to an occluded ICA).
Among the 4 strokes in everted patients, two were major
and two minor. Both major strokes occurred in patients
(one of them was shunted) with a mildly diseased contral-
ateral ICA and were probably embolic (from the aortic
arch or from the heart), because cerebral CT scans demon-
strated a cortical infarction in the territory of the middle
cerebral artery. Both minor strokes were most likely
hemodynamic in nature, as suggested by the CT images:
one developed in the hemisphere contralateral to the
revascularized ICA and ipsilateral to an occluded ICA.
Other complications
Overall, there were 11 perioperative cardiac complica-
tions (0.9%)(Table 2). The only two fatal MIs occurred in
two younger symptomatic patients. Nine patients (0.7%),
one in the older group and 8 in the younger group, had
perioperative congestive heart failure (CHF), including
four patients with a history of CHF. Moreover, one of the
patients with CHF also had a postoperative nonfatal MI.
The incidence of CHF or MI did not statistically differ
between older and younger groups (Table 2). No hyper-
perfusion syndrome was observed in any of the patients.
Other important surgical morbidities included an overall
5% incidence of nerve injury (64 of 1260). The cranial
nerve and the cervical nerve injuries amounted to 4.2%
(54 of 1260) and 0.8% (10 of 1260), respectively: there
Table 2: Perioperative (30-day) results
Total (1099 pts, 1260 
CEAs)
Patients ≥ 80 yrs (n = 
112, 115 CEAs)
Patients < 80 yrs (n = 
987, 1145 CEAs)
p value
Stroke, n(%) 11(0.9) 0 11(0.8) .61
major 9 9
minor 2 2
Death, n(%) 3 (0.2) 0 3 (0.3) 1
stroke-related 1
Cardiac complications, 
n(%)
11(0.9) 1 (0.9) 10 (0.9) 1
fatal 2 2
non-fatal 9 (0.7) 8 (0.7)
Nerve injuries, n(%) 64(5) 4 (3.4) 60 (5.2) .51BMC Cardiovascular Disorders 2006, 6:12 http://www.biomedcentral.com/1471-2261/6/12
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were 31 hypoglossal nerve injuries, 12 recurrent laryngeal
nerve injuries, 7 superior laryngeal nerve injuries, 4 mar-
ginal mandibular nerve injuries, 7 greater auricular nerve
injuries and 3 transverse cervical nerve injuries. All nerve
dysfunctions were transient, and all but 4 recurrent laryn-
geal nerves recovered completely within 6 months of CEA;
2 patients took 12 months to recover and 2 did not
recover until 31 and 37 months later. There was no statis-
tically significant difference between the groups (Table 2).
Comparison of perioperative outcome on CEA and CAS
Comparisons were drawn between the incidence of peri-
operative stroke and death after CEA in patients in this
study aged ≥ 80 years and the representative results from
three recently-published series dealing specifically with
CAS in elderly patients [9,10,19], as given in Table 3. The
outcome was better after CEA than after CAS in all-patient
categories, but the most impressive difference was in the
elderly patients.
Discussion
The results of this study show that CEA for symptomatic
and asymptomatic high-grade carotid disease can be per-
formed safely in patients aged ≥ 80 years, with periopera-
tive stroke risk and death rates comparable with those of
younger patients. This finding is consistent and extends
the results of our two previous studies on early and long-
term outcomes in patients aged 75 or more [20] and in
over 80 year-olds with contralateral carotid occlusion
[21].
Older patients were significantly less likely than younger
patients to have a history of diabetes mellitus and this
could represent a selection bias, with only healthier older
patients being referred for CEA. Though we cannot infer
this from the current data, we do not believe this is the
case. Even if this was, the significantly higher incidence of
arterial hypertension in the older group should counter-
balance any influence of this bias. The two groups had
similar indications for surgery, but older patients had a
statistically higher rate of intraoperative EEG changes sug-
gesting cerebral ischemia and needed shunting statisti-
cally more often than younger patients. This may be
owing to the significantly greater presence of contralateral
ICA occlusion in elderly patients, making the cerebral col-
lateral flow insufficient to withstand the stress of clamp-
ing [22]. Shunting did not appear to have a negative effect
on perioperative outcome, however.
Although there has been concern about the safety and
effectiveness of CEA in patients aged ≥ 80 years, given
their higher risk of complications due to associated
comorbidities and their limited life expectancy, numerous
series have reported excellent results in this patient popu-
lation [23-29], demonstrating that the very elderly could
benefit from CEA even more than others (Table 4).
The suggestion that patients aged ≥ 80 years are good can-
didates for CAS procedures and that CAS is consequently
preferable to CEA in this patient population appears to be
based on two premises that remain to be seen, i.e. that
CEA is a high risk procedure and that CAS is safer than
CEA. The first premise is not supported by the periopera-
tive outcome emerging from our own and many other
institutional series [23-29]. The second is belied by the
analysis of the periprocedural results of the three series
considered [8-10], which revealed an alarming, unaccept-
ably high non-fatal stroke and death rate among the very
elderly, ranging from 11.3% of Hobson's series [10] to 16
Table 3: Periprocedural (30-day) stroke and death incidence 
after carotid angioplasty and stenting by patient age
Author Patients ≥ 80 yrs 
Stroke and death, n(%)
Patients < 80 yrs
 Stroke and death, n(%)
Roubin 9 12/63 (16) 31/465 (6)
Hobson 10 6/53(11.3) 21/650 (3.2)
Kastrup 19 12/99(12.1) N/A
Total 30/215 (13.9) 52/1115(4.7)
N/A = not available.
Table 4: Recent series reporting perioperative outcome for carotid endarterectomy in elderly patients
Author Patients ≥ 80 yrs Patients < 80 yrs
Stroke, n(%) Death, n (%) Stroke,(n %) Death, n(%)
Schultz 23 1/116(0.9) 1/95(1) 1/105 (0.9) 2/90 (2.2)
Treiman 24 4/183 (2.2) 3/146(2) 47/1487(3.2) 12/1176(1)
Perler 25 13/1036(1.2) 14/1036(1.3) 153/8882(1.7) 76/8882(0.8)
Maxwell 26 7/218 (3.2) 2/187 (1) 62/2180(1.4) 31/1783(1.7)
Oszvath 27 1/125 (0.8) 0 33/3932 (0.8) 0
Rockman 28 3/161 (1.9) 0 17/537 (3.2) 2/537 (0.4)
Miller 29 4/360(1.1) 7/360(1.9) 14/1857(0.8) 15/1857(0.8)
Total 33/2199(1.5) 27/2110(1.3) 327/18980(1.7) 138/18257(0.7)BMC Cardiovascular Disorders 2006, 6:12 http://www.biomedcentral.com/1471-2261/6/12
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% of Roubin's series [9], with an overall perioperative
stroke risk and death incidence of 13.9% when the out-
comes of the three series are pooled [8-10]. The conclu-
sion reached by all three studies was that octogenarians
should be considered high-risk patients for CAS proce-
dures and the common practice of recommending CAS for
older patients was questionable and should be aban-
doned until the results of controlled clinical trials become
available.
Limitations of the study
Our study has several drawbacks. Though our data were
collected prospectively, the analysis is retrospective in
nature. Any major and minor perioperative stroke is
unlikely to have been overlooked in our study because all
patients were pre- and postoperatively evaluated by two
board-certified neurologists. The study would have bene-
fited from a comparison of perioperative stroke and death
incidence on symptomatic and asymptomatic patients
aged ≥ 80 years with high-grade carotid stenoses who were
followed up without surgery. Because this study was retro-
spective, we could not (nor did we intend to) analyze data
for patients with indications for CEA who did not
undergo surgery. Moreover, we have no way to knowing
whether our elderly patients are really comparable with
the elderly populations in the CAS series. Unlike our
series, the CAS studies included many recurrent carotid
diseases, while they excluded patients with long subocclu-
sive carotid lesions, whereas many of our patients had sur-
gery for a "string sign" lesion. Finally, though our
institutional outcomes, and those of the CAS series con-
sidered here, may not be representative of more general-
ized experiences with either technique, so attempting to
draw definitive conclusions from the comparison would
be unjustifiable, a non-fatal stroke and death rate of
13.9% would be unacceptable in any patient population.
Conclusion
The conviction that older age means higher risk needs to
be revised. Patients aged ≥ 80 years can undergo CEA with
no greater perioperative risks than younger patients.
Those advocating CAS in "high risk" patients should bear
this in mind, as well as the fact that periprocedural risk of
stroke and death after CAS increases with age. In the light
of our findings, and in good agreement with the low peri-
operative complication rates of many institutional series,
CEA remains the best therapeutic option in elderly
patients with high-grade symptomatic and asymptomatic
carotid stenosis.
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